Clinical Trials Directory

Trials / Completed

CompletedNCT02311686

Non-oxidative Metabolite Profiles After Increasing Doses of Ethanol

Identifying the Profile of the Main Non-oxidative Biomarkers of Alcohol (Ethyl Glucuronide, Ethyl Sulphate, Fatty Acid Ethyl Esters) After the Experimental Exposure to Increasing Doses of Alcohol in Adults.

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
54 (actual)
Sponsor
Parc de Salut Mar · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

The aim of the study is to study the profile of ethanol and non-oxidative biomarkers (ethyl glucuronide, ethyl sulphate and fatty acid ethyl esters) after experimental administration of increasing doses of alcohol in adult subjects.

Detailed description

The abuse of alcohol causes serious health and social problems. Alcohol consumption can be monitored by detecting biomarkers. In current practice indirect biomarkers (mean corpuscular volume, transaminases, gammaglutamyl or carbohydrate-deficient transferrin) are used, although direct biomarkers of alcohol, including alcohol itself and metabolites also exist. Biomarkers of alcohol consumption are used as tools to prevent health and social problems related with alcohol, allowing the identification of subjects at risk of abuse, dependence or withdrawal and to assess the efficacy of treatments for alcohol dependence. Non-oxidative metabolites (ethyl glucuronide, ethyl sulphate and fatty acid ethyl esters) have longer biological half-life than ethanol and accumulate in tissues after consumption. The objective of the study is to study the profile of ethanol and non-oxidative biomarkers (ethyl glucuronide, ethyl sulphate and fatty acid ethyl esters) after experimental administration of increasing doses of alcohol in adult subjects. Subjects will be genotyped for genetic polymorphisms of proteins related to ethanol metabolism and effects (as alcohol dehydrogenase and aldehyde dehydrogenase), and the genotypes will be used to evaluate their influence in the results.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENT10 g ethanolAlcohol single oral dose
DIETARY_SUPPLEMENT20 g ethanolAlcohol single oral dose
DIETARY_SUPPLEMENT40 g ethanolAlcohol single oral dose
DIETARY_SUPPLEMENT60 g ethanolAlcohol single oral dose
DIETARY_SUPPLEMENT80 g ethanolAlcohol single oral dose

Timeline

Start date
2014-12-01
Primary completion
2016-05-01
Completion
2016-05-01
First posted
2014-12-08
Last updated
2016-05-16

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT02311686. Inclusion in this directory is not an endorsement.